Navigation Links
Cloud of smoke over Zyban

Can an anti-smoking drug be injurious to health? Pharma giant GlaxoSmithKline (GSK), under fire regarding its smoking cessation drug, Zyban, has risen in defence of its non-nicotine oral drug - in the wake of unproven reports in the UK, linking the drug to adverse reactions and deaths. //

Touted to be the world’s most successful smoking cessation drug, Zyban received a high decibel launch in India in June 2001. The cause for concern, however, was a safety update on the site of British regulatory body, Medicines Control Agency (MCA). The update, suggesting an unproven association between the tobacco-cessation drug and 57 deaths in the UK, spurred media-reports abroad casting a cloud over Zyban and subsequently causing a ripple effect in domestic circles.

Mr Kal Sundaram, GSK’s Director-Pharmaceuticals, told that regulatory bodies such as MCA of the UK and the FDA of the US have celared the drug and have said that “there were no reports directly linking the deaths to Zyban”. Zyban is a prescription drug and GSK would continue to sell it across world markets, he said. Endorsing the safety profile of Zyban, GSK said: “Death (the 57 reported deaths) was most commonly due to cardiovascular causes and where information on medical history was provided, most patients had a history of cardiovascular disease or risk factors for cardiovascular disease in addition to smoking.”

According to GSK reports in the UK, sales had slumped 34 per cent to 22 million pounds ($31 million) in the three months between October to September last year following media coverage of the reported deaths. Zyban, when launched, had come with its cautions saying: “For majority of smokers, side effects of Zyban are not a concern. Zyban is generally well tolerated. Side effects are mild and include dry mouth and insomnia.....should be used cautiously, if at all, in patients with seizure disorder and in those taking alcohol during treament.”
'"/>




Page: 1

Related medicine news :

1. Smokers Cloud Has A Silver Lining?
2. IMF considers Bird Flu to be a Dark Cloud
3. Half of worlds children are passive smokers - damning disclosure from WHO
4. Glaxo launches pills to help smokers quit in 7-12 weeks
5. Emotional trigger to smoke
6. Poor diet among smokers
7. Pregnant smokers could harm their child
8. Drinkers and smokers are at risk
9. A new method to help smokers quit
10. What makes young girls smoke
11. Poor diet among smokers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and high ... to apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. The ... can receive up to $3,000. , The grant is named after California ...
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... thrilled to formally announce its Not a Moment to Lose fundraising campaign. As ... rally supporters dedicated to declaring victory over cancer. The campaign aims to raise ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 2016 , ... METTLER TOLEDO has launched its online ... papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user manuals, ... webinars and videos available online, visit the METTLER TOLEDO Expertise Library . ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016   Mallinckrodt Pharmaceuticals (NYSE: ... announced that it received a perfect score of 100 ... national benchmarking survey and report on corporate policies and ... workplace equality, administered by the Human Rights Campaign (HRC) ... businesses which also earned top marks this year. ...
(Date:12/5/2016)... Dec. 5, 2016 ... antibiotics have emerged as a crucial class of ... In addition, antibiotics are also used for prophylactic ... immunocompromised patients (cancer patients undergoing chemotherapy). However, the ... food production, has rapidly accelerated an evolutionary response ...
(Date:12/5/2016)... 5, 2016 Special purpose needles are used in ... fluid and cells from organs or lumps and are available ... The global market for special purpose needles is showing a ... of revenue, the global special purpose needles market is projected ... period (2016–2026) and is expected to be valued at US$ ...
Breaking Medicine Technology: